3 reports

Gerald Cagle said: " I am delighted to join Eyevensys' Board and look forward to working with a strong team and unlock the potential of its pioneering ocular drug delivery technology.

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • Protein Therapy
  • Therapy

Gerald Cagle said: " I am delighted to join Eyevensys' Board and look forward to working with a strong team and unlock the potential of its pioneering ocular drug delivery technology.

  • Immunotherapy
  • Monoclonal Antibody
  • Protein Therapy
  • Therapy
  • Promethera Biosciences S.A.

The company offers its products through its proprietary FluidCrystal drug delivery technologies such as injection depot, topical bioadhesive delivery, and nanoparticle delivery technologies.

  • Blood Disease
  • Chemotherapy
  • Pharmaceutical
  • Protein Therapy
  • Product Initiative